Thyroid hormone activates Akt and prevents serum starvation-induced cell death in neonatal rat cardiomyocytes

被引:98
作者
Kuzman, JA
Gerdes, AM
Kobayashi, S
Liang, QR
机构
[1] Univ S Dakota, Cardiovasc Res Inst, Sch Med, Sioux Falls, SD 57105 USA
[2] S Dakota Hlth Res Fdn, Sioux Falls, SD 57105 USA
关键词
thyroid hormone; Akt; cell death;
D O I
10.1016/j.yjmcc.2005.07.019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thyroid hormone is known to cause hypertrophy, tachycardia, vasorelaxation, and enhanced contractile function. The exact mechanisms responsible for these effects are unknown but classical regulation of gene expression through binding to nuclear receptors has been widely implicated. Data have also accumulated suggesting that TH can exert effects through non-classical mechanisms involving activation of signal transduction pathways. Whether thyroid hormone can activate signal transduction pathways in the heart is unknown. In this study, we treated neonatal rat cardiomyocytes with T3 and determined the expression and phosphorylation of signaling molecules. T3 caused specific activation of Akt/PKB signaling after 24 h of treatment. Since Akt is known to protect against cell death, cells were serum-starved in the presence or absence of T3 to determine whether T3 could protect against serum starvation-induced cell death. Indeed, myocytes treated with T3 displayed enhanced sarcomeric structure after 4 days of serum starvation. T3 increased cell viability as measured by MTT assays, prevented DNA laddering, and reduced TUNEL positive cells, which was associated with increased phosphorylated Akt and glycogen synthase kinase 3(3 (GSK-3 beta). The protective effect of T3 on cell viability, DNA laddering and TUNEL positive cells were blocked by LY294002, a phosphoinositide-3 kinase (PI3K) inhibitor that blocks Akt signaling. Overall these data suggest that T3 can activate Akt in cardiomyocytes which protects myocytes against cell death. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:841 / 844
页数:4
相关论文
共 14 条
[1]   Silent information regulator 2α, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes [J].
Alcendor, RR ;
Kirshenbaum, LA ;
Imai, S ;
Vatner, SF ;
Sadoshima, J .
CIRCULATION RESEARCH, 2004, 95 (10) :971-980
[2]   Thyroid hormone metabolism in patients with congestive heart failure: The low triiodothyronine state [J].
Ascheim, DD ;
Hryniewicz, K .
THYROID, 2002, 12 (06) :511-515
[3]   Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts [J].
Cao, X ;
Kambe, F ;
Moeller, LC ;
Refetoff, S ;
Seo, H .
MOLECULAR ENDOCRINOLOGY, 2005, 19 (01) :102-112
[4]   Long-term caspase inhibition ameliorates apoptosis, reduces myocardial troponin-I cleavage, protects left ventricular function, and attenuates remodeling in rats with myocardial infarction [J].
Chandrashekhar, Y ;
Sen, S ;
Anway, R ;
Shuros, A ;
Arland, I .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (02) :295-301
[5]  
Clerk A, 1999, AM J CARDIOL, V83, p64H
[6]   Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice [J].
Condorelli, G ;
Drusco, A ;
Stassi, G ;
Bellacosa, A ;
Roncarati, R ;
Iaccarino, G ;
Russo, MA ;
Gu, YS ;
Dalton, N ;
Chung, C ;
Latronico, MVG ;
Napoli, C ;
Sadoshima, J ;
Croce, CM ;
Ross, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (19) :12333-12338
[7]   Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface [J].
Davis, FB ;
Mousa, SA ;
O'Connor, L ;
Mohamed, S ;
Lin, HY ;
Cao, HJ ;
Davis, PJ .
CIRCULATION RESEARCH, 2004, 94 (11) :1500-1506
[8]   Nongenomic actions of thyroid hormone on the heart [J].
Davis, PJ ;
Davis, FB .
THYROID, 2002, 12 (06) :459-466
[9]   Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Gαq transgenic mice [J].
Hayakawa, Y ;
Chandra, M ;
Miao, WF ;
Shirani, J ;
Brown, JH ;
Dorn, GW ;
Armstrong, RC ;
Kitsis, RN .
CIRCULATION, 2003, 108 (24) :3036-3041
[10]   Low-T3 syndrome - A strong prognostic predictor of death in patients with heart disease [J].
Iervasi, G ;
Landi, P ;
Raciti, M ;
Ripoli, A ;
Scarlattini, M ;
L'Abbate, A ;
Donato, L .
CIRCULATION, 2003, 107 (05) :708-713